|
|
Memory Disorders - Chemically induced
Research News and Information
Definition of 'Memory Disorders'Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions. Common names: Memory Disorders; Memory Disorder; Retention Disorders, Cognitive; Cognitive Retention Disorder; Cognitive Retention Disorders; Retention Disorder, Cognitive; Memory Loss; Memory Losses; Memory Disorder, Semantic; Memory Disorders, Semantic; Semantic Memory Disorders; Semantic Memory Disorder |
Saturday, November 21, 2009
5 Oct 2009
The integrity of the hippocampus is critical for both spatial navigation and episodic memory, but how its neuronal firing patterns underlie those functions is not well understood. In particular, the modality by which hippocampal place cells ... Read more...
Prenatal phencyclidine exposure alters hippocampal cell proliferation in offspring rats.
30 Aug 2009
Multiple case reports have described pregnancy in phencyclidine hydrochloride (PCP) abusers. Characteristic clinical symptoms of PCP-exposed infants have revealed neurobehavioral or physical abnormalities. We designed this study to evaluate whether ... Read more...
Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling.
31 Jul 2009
Cognitive impairment is one of the most important negative consequences associated with cannabis consumption. We found that CB1 cannabinoid receptor (CB1R) activation transiently modulated the mammalian target of rapamycin (mTOR)/p70S6K pathway and ... Read more...
Latest indexed articles for 'Memory Disorders - Chemically induced'
These are the very latest articles for this heading:
- Alteration of theta timescale dynamics of hippocampal place cells by a cannabinoid is associated with memory impairment.
5 Oct 2009 - Prenatal phencyclidine exposure alters hippocampal cell proliferation in offspring rats.
30 Aug 2009 - Get stoned in GABAergic synapses.
30 Aug 2009 - Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling.
31 Jul 2009 - Lidocaine, tetrodotoxin and their effect on consolidation of spatial memory.
30 Jul 2009 - Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.
26 Jul 2009 - Lanthanum chloride impairs memory, decreases pCaMK IV, pMAPK and pCREB expression of hippocampus in rats.
26 Jul 2009 - Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task.
21 Jul 2009 - Increased apoptosis and reduced neuronal and glial densities in the hippocampus due to nicotine and ethanol exposure in adolescent mice.
29 Jun 2009 - Overactive bladder medications: do they cause memory loss?
29 Jun 2009 - Statin-associated adverse cognitive effects: survey results from 171 patients.
29 Jun 2009 - Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.
19 Jun 2009 - The nitric oxide (NO) donor molsidomine antagonizes scopolamine and L-NAME-induced performance deficits in a spatial memory task in the rat.
6 Jun 2009 - Behavioral and cognitive alterations, spontaneous seizures, and neuropathology developing after a pilocarpine-induced status epilepticus in C57BL/6 mice.
Jun 2009 - The role of telencephalic NO and cGMP in avoidance conditioning in goldfish (Carassius auratus).
30 May 2009 - Pharmacological intervention of hippocampal CA3 NMDA receptors impairs acquisition and long-term memory retrieval of spatial pattern completion task.
21 May 2009 - Physical exercise improves motor and short-term social memory deficits in reserpinized rats.
18 May 2009 - The ameliorating effects of NMDA receptor agonists on histamine H1 antagonist-induced memory and hippocampal theta disruptions are prevented by the H3 receptor agonist in rats.
18 May 2009 - Total absence of recall of discussion occurred shortly after ingestion of 10 mg zolpidem.
16 May 2009 - Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.
6 May 2009
See a longer list of these articles.
Technical information about 'Memory Disorders'
Definition: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
Descriptor UI: D008569
Alternative terms: Memory Disorders; Memory Disorder; Retention Disorders, Cognitive; Cognitive Retention Disorder; Cognitive Retention Disorders; Retention Disorder, Cognitive; Memory Loss; Memory Losses; Memory Disorder, Semantic; Memory Disorders, Semantic; Semantic Memory Disorders; Semantic Memory Disorder; Memory Disorder, Spatial; Memory Disorders, Spatial; Spatial Memory Disorders; Spatial Memory Disorder; Age-Related Memory Disorders; Age Related Memory Disorders; Age-Related Memory Disorder; Memory Disorder, Age-Related; Memory Disorders, Age-Related; Memory Disorders, Age Related; Memory Deficits; Deficit, Memory; Deficits, Memory; Memory Deficit;
Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; diagnosis; diet therapy; drug therapy; economics; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; rehabilitation; surgery; therapy; urine; ultrasonography; virology;
Tree Number: C10.597.606.525; C23.888.592.604.529; F01.700.625;
History Note: 1969